Menu Back toClinically Meaningful: How is it Different from Statistical Significance?

DIA 2021 Global Annual Meeting

Clinically Meaningful: How is it Different from Statistical Significance?

Session Chair(s)

Anil  Bhojwani, MPharm

Anil Bhojwani, MPharm

  • Sr. Manager (Sr Group Lead), Global Clinical Communication
  • Eli Lilly and Company, India
An interactive session to compare clinically meaningful results with statistical significance results, share tips and techniques to interpret clinically significant results, followed by live examples and demonstration of interpretation of results.
Learning Objective : Describe how p-values are used by clinicians and regulatory authorities to make decisions about treatments; Identify the risks associated with the use/over-use of p-values; Discuss how clinical relevance fits in to the discussion and how it is just as, if not more, important than p-values; Describe discussions ongoing in the statistics community about the use of p-values.


Stephen  Corson, PhD

Making Sense of it All: P-Values Versus Clinical Relevance

Stephen Corson, PhD

  • Principal Statistician
  • PHASTAR, United Kingdom